RTI International to serve as data coordinating center for study of pregnant women in Zika affected areas

RTI International will serve as the data coordinating center for a multi-country study to evaluate the magnitude of health risks that Zika virus infection poses to pregnant women and their developing fetuses and infants. The study is led by the National Institutes of Health and Fundacao Oswaldo Cruz-Fiocruz.

The study begins in Puerto Rico and will expand to several locations in Brazil, Colombia, Guatemala and other areas that are experiencing active local transmission of the virus.

  Learn about the COVID-19 pandemic from News Hour  

“By serving as the data coordinating center, we will be able to help this multisite study monitor data and develop tools necessary to support the development of treatment and prevention strategies for addressing Zika,” said Elizabeth McClure, Ph.D., perinatal epidemiologist at RTI International and principal investigator of the data coordinating center.

Zika virus is spread primarily through bites from infected Aedes aegypti mosquitoes, although other forms of transmission—notably, mother-to-child and sexual transmission—also occur. Active virus transmission currently is ongoing in 60 countries and territories. The virus has been linked to a spike in cases of microcephaly, a condition in which babies are born with abnormally small heads and possible neurological damage. In addition to microcephaly, other problems have been detected in pregnancies and among fetuses and infants infected with Zika virus before birth, including miscarriage, stillbirth, absent or poorly developed brain structures, eye defects, hearing deficits, and impaired growth.

The Zika in Infants and Pregnancy (ZIP) study aims to enroll as many as 10,000 pregnant women ages 15 years and older at up to 15 sites. The participants will be in their first trimester of pregnancy and will be followed throughout their pregnancies to determine if they become infected with Zika virus and if so, what outcomes result for both mother and child. The participants’ infants will be carefully followed for at least one year after birth.

The National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Environmental Health Sciences (NIEHS), all part of the NIH, are funding and conducting the study, along with Fiocruz.

The researchers plan to compare birth outcomes between mothers who were infected with Zika virus and those who were not, documenting the frequency of miscarriage, preterm birth, microcephaly, malformations of the nervous system, and other complications. The researchers also seek to compare the risk of pregnancy complications among women who have symptoms of Zika virus infection and those who are infected but do not have symptoms. Additionally, the study will evaluate how the timing of infection affects pregnancy outcomes and the role environmental influences, social determinants and other infections, such as dengue virus infection, may play on the health of the study participants and their newborns.

Women participating in the ZIP study will be monitored monthly for the duration of their pregnancies and then six weeks after delivery. They will have a physical examination and be asked to provide blood, urine, saliva and vaginal swab samples at study entry and at each monthly prenatal care visit. If the participants note that they will be receiving an amniocentesis in connection with their clinical care, the research team will arrange with the participant and her obstetrician to obtain a sample of the amniotic fluid to test for Zika infection. The participants will be instructed about the signs and symptoms of acute Zika virus infection and will be asked to notify their clinic immediately if they experience symptoms. Post-delivery, a breast milk sample, if available, will be obtained for Zika testing. Infants whose mothers consent to their participation in the study will be evaluated within 48 hours of birth and again at three, six and 12 months.

It is important to note that the ZIP study is a research effort that is distinct from and complementary to public health registries underway in the United States (U.S. Zika Public Health Registry), Puerto Rico (Zika Active Pregnancy Surveillance System), and Colombia (SIVIGILA/Projecto Vez). These registries are population-based and collect observations from medical evaluations and testing with the intent of providing information for public health action.

Follow News Hour

Mridha Shihab Mahmud is a writer, content editor and photojournalist. He works as a staff reporter at News Hour. He is also involved in humanitarian works through a trust called Safety Assistance For Emergencies (SAFE). Mridha also works as film director. His passion is photography. He is the chief respondent person in Mymensingh Film & Photography Society. Besides professional attachment, he loves graphics designing, painting, digital art and social networking.
No Comments